Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 5
Submit an article Journal homepage
163
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Inpatient hospitalization’s associated cost and mortality in myeloma patients undergoing autologous stem cell transplant: a 13-year analysis of the National Inpatient Sample

Saqib AbbasiDivision of Hematologic Malignancies and Biomolecular Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA;
,
Alec BrittDivision of Hematologic Malignancies and Biomolecular Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0001-7084-7053
ORCID Icon,
Brian McCluneDivision of Hematologic Malignancies and Biomolecular Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA;
,
Leyla ShuneDivision of Hematologic Malignancies and Biomolecular Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA;
,
Suman KambhampatiKansas City VA Medical Center, Kansas City, KS, USA
&
Ghulam Rehman MohyuddinDivision of Hematologic Malignancies and Biomolecular Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA;
Pages 1254-1256 | Received 15 Oct 2019, Accepted 13 Jan 2020, Published online: 07 Feb 2020

References

  • Barlogie B, Hall R, Zander A, et al. High-dose melphalan with autologous bone marrow transplantation for multiple myeloma. Blood. 1986;67(5):1298–1301.
  • Al Hamed R, Bazarbachi AH, Malard F, et al. Current status of autologous stem cell transplantation for multiple myeloma. Blood Cancer J. 2019;9(4):44–44.
  • Shah N, Cornelison AM, Saliba R, et al. Inpatient vs outpatient autologous hematopoietic stem cell transplantation for multiple myeloma. Eur J Haematol. 2017;99(6):532–535.
  • Holbro A, Ahmad I, Cohen S, et al. Safety and cost-effectiveness of outpatient autologous stem cell transplantation in patients with multiple myeloma. Biol Blood Marrow Transplant. 2013;19(4):547–551.
  • Kodad SG, Sutherland H, Limvorapitak W, et al. Outpatient autologous stem cell transplants for multiple myeloma analysis of safety and outcomes in a tertiary care centre. Biol Blood Marrow Transplant. 2018;24(3):S50.
  • HCUP National Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP). Agency for healthcare research and quality, R., MD. 2002–2014. [cited 2020 Jan 21]. Available from: http://www.hcup-us.ahrq.gov/nisoverview.jsp
  • Nemunaitis J, Rabinowe SN, Singer JW, et al. Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer. N Engl J Med. 1991;324(25):1773–1778.
  • Kumar G, Kumar N, Taneja A, et al. Nationwide trends of severe sepsis in the 21st century (2000–2007). Chest. 2011;140(5):1223–1231.
  • Horton LE, Haste NM, Taplitz RA. Rethinking antimicrobial prophylaxis in the transplant patient in the world of emerging resistant organisms-where are we today? Curr Hematol Malig Rep. 2018;13(1):59–67.
  • Gertz MA, Ansell SM, Dingli D, et al. Autologous stem cell transplant in 716 patients with multiple myeloma: low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiative. Mayo Clin Proc. 2008;83(10):1131–1135.
  • HCUP Fast Stats, Healthcare Cost and Utilization Project (HCUP). 2019. [cited 2020 Jan 21]. Available from: www.hcup-us.ahrq.gov/
  • Maziarz RT, Driscoll D. Hematopoietic stem cell transplantation and implications for cell therapy reimbursement. Cell Stem Cell. 2011;8(6):609–612.
  • Neil Dunavin LWM, Meyer CL, Divine C, et al. Health care reimbursement and service utilization among Medicare beneficiaries with multiple myeloma receiving autologous hematopoietic cell transplantation in inpatient and outpatient settings. Blood. 2018;1(132):832–832.
  • Woolhandler S, Himmelstein DU. The high costs of for-profit care. CMAJ. 2004;170(12):1814–1815.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.